OBD is a global biotech company advancing personalized healthcare by developing and commercializing #PrecisionMedicine tests for life-changing diseases.
Oxford, UK
Joined August 2020
- Tweets609
- Following203
- Followers479
- Likes207
Heading to #ASHG26? Genomics is great at generating sequences, less so at explaining them. EpiSwitch® Orion predicts 3D regulatory genome architecture from #WGS, so you can ask new questions of your data. Meet our CEO & CTO at #ASHG with the Mobile App. #OBD @GeneticsSociety
100 days in as CEO of Oxford BioDynamics (#OBD), Rich Compton sat down with us to talk about what’s surprised him and where he sees #3Dgenomics heading. Read the full conversation here 👉 obdx.co/wa5
#PrecisionMedicine #Genomics @OxBioDynamics
Oxford BioDynamics retweeted
Dr Garrett Pohlman presented "Urology Updates” at the Nebraska Academy of Family Physicians conference (#NAFP), highlighting how #EpiSwitchPSE is supporting earlier, high-fidelity #prostatecancer evaluation in everyday practice across #Nebraska.
#OBD #PSE @gpohlmanmd @NEBRAFP
Oxford BioDynamics retweeted
The Sunday Times covered a study using #EpiSwitchOrion, #OBD's AI-enabled discovery platform. @thetimes spoke to Prof Pshezhetskiy of the #UEA Norwich Medical School about the work, and what it could mean for ME/CFS, long COVID, PTSD, RA, MS (paywalled): obdx.co/jej
Oxford BioDynamics retweeted
🎙️ Dr Garrett Pohlman joined Dr Tom Rogers on an episode of The Common Sense MD to discuss why #PSA doesn't tell the full #ProstateCancer story, and how #EpiSwitchPSE adds clarity before biopsy or imaging. youtu.be/Z1vqyGPeHBg
@OxBioDynamics #OBD #PSE #urology @gpohlmanmd
Oxford BioDynamics partners with Dubai London Clinics & Hospitals to bring #EpiSwitchPSE to the UAE, our first commercial partnership for the #prostatecancer detection test in the Gulf region. Read more: mypse.co/d8t
#OBD #PSE #urology #UAE #Dubai @94percent_com
#OBD CSO Dr Akoulitchev discusses how #EpiSwitch #3Dgenomics was applied to #MECFS. The unique signature that we found distinguished severe chronic fatigue syndrome from healthy controls with 96% accuracy in a study published in the Journal of Trans Med: obdx.co/mqd
We are pleased to announce today that the company (#OBD) has raised £9.15 million with new and existing institutional and other investors, subject to shareholder approval. Read more here: obdx.co/f3x
#OBD announces its first commercial agreement for EpiSwitch Orion, supporting the OPTIMISE psoriatic arthritis research programme funded by @DHSCgovuk via @NIHRresearch with @UniofOxford @OxfordMedSci @ndorms, @UofGlasgow, @KingsCollegeLon and @GSTTnhs.
👉 obdx.co/op4
"What I've Learned from More Than 500 PSE Orders"
— We sat down with Dr @gpohlmanmd, board-certified #urologist and an experienced clinical user of #EpiSwitchPSE. He covers how #PSE fits into #prostatecancer evaluation 👇
mypse.co/qa500
@94percent_com #OBD #urology #ad
Oxford BioDynamics retweeted
We've partnered with MK Commercial Group, a specialist #lifesciences commercialisation organisation, to extend @OxBioDynamics' US commercial presence and drive growth of #EpiSwitchPSE. Read more: obdx.co/m1t
#OBD #AIM #EpiSwitch #PSE #diagnostics #urology
We're pleased to announce the appointment of Richard Compton as CEO of Oxford BioDynamics. The former Oxford Nanopore and Illumina commercial executive has been appointed to lead the next phase of #OBD's development. Read more: obdx.co/i8g
🎙️#EpiSwitchPSE featured on Health Uncensored with Dr. Drew.
Urologist @gpohlmanmd discussed how #PSE delivers a clear result with 94% accuracy from a blood draw, bringing clarity to the #prostatecancer diagnostic pathway.
Full story: 🔗obdx.co/ddw
@94percent_com #OBD
🇺🇸 #Hiring: Clinical Lab Associate II | Frederick, MD.
Join Oxford BioDynamics' US lab, home of the #EpiSwitchPSE 94% accurate prostate cancer detection test. Apply 👉 obdx.co/8yy
#OBD #EpiSwitch #BiotechJobs #ClinicalLab @94percent_com
#EpiSwitchPSE featured on Health Uncensored with Dr. Drew—now on YouTube. The advanced, 94% accurate blood test built to bring clarity to #prostatecancer detection.
▶️ Watch it here: youtu.be/oP42-jsV18Y
@94percent_com @HUwithDrDrew @FoxBusiness @gpohlmanmd #urology #OBD #PSE
Oxford BioDynamics retweeted
Honored to join Dr. Drew this evening (4 PM CST / 5 PM EST) on Fox Business Network’s - Dr. Drew’s Health Uncensored to discuss the evolving landscape of #ProstateCancer screening and detection.
Oxford BioDynamics retweeted
This Sunday on @HUwithDrDrew: 3 in 4 raised PSA results aren't #prostatecancer. So what comes next?
—Urologist @gpohlmanmd shares what he's seeing using the breakthrough #EpiSwitchPSE test from @OxBioDynamics #OBD, shown to boost accuracy to 94%. 📺17 May 5pm ET @FoxBusiness #PSE
Oxford BioDynamics retweeted
🎬 Go behind the scenes with @gpohlmanmd in the green room ahead of Health Uncensored with Dr Drew on @FoxBusiness. The national conversation on accurate #prostatecancer testing with #EpiSwitchPSE is about to hit prime time.
📺 Sun 17 May, 5pm ET
@HUwithDrDrew @OxBioDynamics #OBD
Up to 79% of prostate biopsies could be avoided. That's the headline from a #ProstateCancer study using #EpiSwitchPSE testing, presented at #LUGPA2026 by Dr @gpohlmanmd—and 100% of patients chose to take the #PSE when offered. More at: mypse.co/lp26
#OBD @94percent_com
